What are the opening hours?

Monday 6am - 5pm Tuesday 6am - 5pm Wednesday 6am - 5pm Thursday 6am - 5pm Friday 6am - 5pm

ProSomnus Sleep Technologies

Home
United States
Pleasanton, CA
ProSomnus Sleep Technologies

ProSomnus’s patient preferred devices are more comfortable, effective and less invasive than CPAP. To learn more, visit www.ProSomnus.com.

ProSomnus (NASDAQ: OSA) is a leading CPAP alternative for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each

patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government sponsored healthcare plans around the world, representing over 200 million covered lives.

07/28/2025

Every ProSomnus Sleep Technologies EVO Guided device is:
✅ 100% custom-fabricated
✅ Based exclusively on the provider’s prescription
✅ Free of prefabricated parts or post-fabrication modifications

🔹 ProSomnus Sleep Technologies, The Leading non-CPAP OSA Therapy®

📩 Contact your ProSomnus Representative or Email Info@ProSomnus.com to learn more about prescribing EVO Guided as your frontline device. 🕸️ProSomnus.com

07/24/2025

Discover what’s next in care at 2025! ✨

Join renowned sleep medicine experts from around the globe for an insightful symposium, "Beyond Mandibular Advancement: Science,
Innovation and Outcomes," exploring the future of Obstructive Sleep Apnea treatment. This dynamic session led by three international leaders will spotlight breakthrough approaches that move beyond traditional mandibular advancement, emphasizing precision, personalization, and real-world outcomes that elevate patient care. 💤👇

Danny J. Eckert, PhD (Australia)
Stepwise Add-On and Endotype-Informed Targeted
Combination Therapy to Treat OSA.

Olivier M. Vanderveken, MD, PhD (Belgium)
Effectiveness of Oral Appliance Therapy as First-Line
Treatment Compared with CPAP: The FLOSAT Study.

Edward T. Sall, MD, DDS, MBA (USA)
ProSomnus RPMO₂ Device with Embedded
Oxygen Sensor.

📅 Sept 8 | 12:45–1:45pm | Room 326 – flag the session & visit Booth 410 for hands-on demos.

ProSomnus Sleep Technologies, the leading non-CPAP OSA therapy®

worldsleepcongress.com | ProSomnus.com | World Sleep Society

😴🌐

07/23/2025

“The lingual-less design, refined post structure, and precision engineering of EVO Guided provide greater tongue space and comfort—key factors in enhancing efficacy and patient outcomes.”

— Michael Gelb, DDS, MS (The Gelb Center)
https://www.gelbcenter.com/

The Gelb Center | ProSomnus.com | ProSomnus Sleep Technologies

07/21/2025

✨ Meet the future of Oral Appliance Therapy: ProSomnus Sleep Technologies EVO® Guided.

The only device bioengineered to dilate the velopharynx and the oropharynx—advancing the science of OSA treatment. 100% made from the provider’s oral records, no prefabricated components and no modifications from your prescription.

➡️ Optimize Efficacy, Patient Satisfaction, Referrals, and Adherence
➡️ Mitigate Side Effects
➡️ Boost practice economics by reducing costly non-responder patients

🔹 ProSomnus Sleep Technologies, The Leading non-CPAP OSA Therapy®

📩 Contact your ProSomnus Representative or Email Info@ProSomnus.com to learn more about prescribing as your frontline device.

07/18/2025

🎤🌟Hear from industry leading sleep medicine leaders transforming OSA therapy—live at the ProSomnus Sleep Technologies Sponsored Symposium "Beyond Mandibular Advancement: Science, Innovation and Outcomes," exploring the future of Obstructive Sleep Apnea treatment at World Sleep 2025 in Singapore:

Danny J. Eckert, PhD (Australia)
Stepwise Add-On and Endotype-Informed Targeted
Combination Therapy to Treat OSA 🤝

Olivier M. Vanderveken, MD, PhD (Belgium)
Effectiveness of Oral Appliance Therapy as First-Line
Treatment Compared with CPAP: The FLOSAT Study 📑

Edward T. Sall, MD, DDS, MBA (USA)
ProSomnus RPMO₂ Device with Embedded
Oxygen Sensor 🔋

📅 Sept 8 | 12:45–1:45pm | Room 326 – then visit Booth 410 to explore the latest product innovations, including ProSomnus EVO® Guided

ProSomnus Sleep Technologies, the leading non-CPAP OSA therapy®

worldsleepcongress.com | ProSomnus.com

💡🛌

07/17/2025

“The new ProSomnus EVO Guided device is super easy for insertion; offers a perfect fit every time and patients have reported it to be extremely comfortable. Given the very low profile and lingual-less design, it’s becoming a preferred device option for our GoTo Sleep Centers.”

— Stacey C. Layman DDS, D-ABDSM (GoTo Sleep Center)
https://www.gotosleepcenter.com/

GoTo SLEEP Center - Scottsdale | ProSomnus Sleep Technologies | ProSomnus.com

07/16/2025

🧠 ProSomnus Sleep Technologies EVO Guided is the only device bioengineered to dilate the velopharynx and the oropharynx—targeting the root of airway collapse.

It simultaneously:
✔ Stabilizes and titrates the mandible
✔ Encourages anterior tongue positioning
✔ Promotes complete mouth closure

🔹 ProSomnus Sleep Technologies, The Leading non-CPAP OSA Therapy®

📩 Contact your ProSomnus Representative or Email Info@ProSomnus.com to learn more about prescribing EVO Guided as your frontline device.

07/04/2025

This Fourth of July, we celebrate the spirit of independence, the warmth of community, and the joy of time well spent with those we love. 🇺🇸✨

Wishing you a safe, restful, and meaningful holiday filled with laughter, connection, and peace of mind.

From our family to yours — Happy Independence Day! 💙🤍❤️

🔹 ProSomnus Sleep Technologies, The Leading non-CPAP OSA Therapy®

07/02/2025

📢 LIVE WEBINAR ALERT 📢

Join ProSomnus Sleep Technologies on Wednesday, July 2 at 5pm PT to discuss, “From Mandibular Advancement to Hyo-glossal Repositioning: Chasing 100% Success”.

Airway collapse is a primary concern in Obstructive Sleep Apnea (OSA), with 94% involving the velopharynx. Traditional mandibular advancement primarily dilates the oropharynx but offers only indirect effects on the velopharynx. ProSomnus Sleep Technologies EVO® Guided is the only device bioengineered to dilate the velopharynx and the oropharynx, delivering a targeted, patient-specific solution for improved outcomes.

This webinar will explore:
➡️ Clinical feedback from industry leading DSM providers prescribing EVO Guided
➡️ How EVO Guided precisely repositions the mandible for optimal airway dilation
➡️ The role of anterior tongue posture and mouth closure guidance in OSA management
➡️ Why EVO Guided is 100% patient-specific, made entirely from provider records—no prefabricated components, no modifications

Join us to learn how EVO Guided is redefining Oral Appliance Therapy with precision-engineered, non-CPAP innovation.

Panelists:
Dr. Kent Smith
Dr. Dave Federici
Dr. John Carollo
Dr. Charles Tozzer
Dr. Michael Murray
Dr. Ben Utterback
Dr. Saleema Adatia
Dr. Dana Blalock
Dr. Eddie Sall
And more…

🔗 Register here: https://loom.ly/MA-z9hI

🔹 ProSomnus Sleep Technologies, the leading non-CPAP OSA therapy®

ProSomnus.com

Address

Pleasanton, CA

Opening Hours

Monday	6am - 5pm
Tuesday	6am - 5pm
Wednesday	6am - 5pm
Thursday	6am - 5pm
Friday	6am - 5pm

Telephone

+18445375337

Website

http://www.ProSomnus.com/

Alerts

Be the first to know and let us send you an email when ProSomnus Sleep Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ProSomnus Sleep Technologies: